Is CoQ10 better than urolithin A?

For most people, yes. CoQ10 scores 7.1 against 6.5, takes five of the eight use-case rows, and costs two to six times less. Urolithin A wins the muscle row 5.0 to 2.0 and ties mitochondrial at 7.0 each. If your target is cardiac, statin muscle pain, antioxidant capacity or fertility, CoQ10 is not a close call.

What is the difference between urolithin A and CoQ10?

CoQ10 is a working part of the mitochondrion. It carries electrons between Complexes I and III to make ATP, and protects membranes and LDL from oxidation. Urolithin A is a cleanup signal that supports selective mitophagy through the PINK1 and Parkin pathway, tagging damaged mitochondria for recycling. One runs the machine, the other retires broken ones.

Can I take urolithin A and CoQ10 together?

Mechanistically it makes sense, since clearing damaged mitochondria and supplying the electron carrier are complementary rather than overlapping. No human trial has tested the combination, so treat it as an untested hypothesis costing roughly $65 to $140 a month. Run CoQ10 alone for 12 weeks first, then decide.

Which one is cheaper?

CoQ10, by two to six times. Generic ubiquinone runs $15 to $40 a month at 200 mg a day and ubiquinol runs $30 to $60. Branded Mitopure runs $50 to $100 a month at 500 mg a day. Both priced 2026-09-07. Generic urolithin A is cheaper but was not the material used in any published human trial.

How long before I know if either is working?

CoQ10 gives a first noticeable change around week 2, full effect at week 12, and asks for a 12-week assessment window. Urolithin A takes about 4 weeks for a first change, full effect at 16 weeks, and a 16-week window. Pick your marker before you start, then judge at the window rather than on how you feel in week two.

Will either one give me more energy?

Only if you are starting from a deficit. CoQ10 scores 6.0 on energy and exercise capacity improved in heart-failure patients, but the controlled evidence for healthy replete people is thin. Urolithin A scores 4.0 with mixed subjective reports. I ran Mitopure at 500 mg a day for about 90 days and noticed no clear subjective effect.

Should I buy ubiquinol or ubiquinone?

Ubiquinol if you are over fifty or absorb poorly, ubiquinone if price is the constraint. Langsjoen 2014 measured plasma CoQ10 at 4.3 against 2.5 micrograms per milliliter at 200 mg a day of each form. Either way take it with the fattiest meal of the day, because absorption is poor without dietary fat.

Who should avoid these?

Anyone on warfarin should not take CoQ10 without INR monitoring, since it resembles vitamin K2 and can blunt the anticoagulant. Neither belongs in pregnancy or breastfeeding without clinician guidance. CoQ10 also rules out high-dose selenium co-supplementation outside the studied combination, and replacing guideline heart-failure therapy or a needed statin. Urolithin A rules out pediatric use, unverified generic product, and use as a disease treatment.

Head-to-Head Comparison

Urolithin A vs CoQ10: Which Is Better for Energy?

Should I take urolithin A or CoQ10?

Reviewed 09/07/2026

CoQ10 scores 7.1 and urolithin A scores 6.5, so CoQ10 wins on the numbers and costs two to six times less. It takes cardiovascular, energy, antioxidant and both fertility rows. Mitochondrial is a real 7.0 to 7.0 tie on different mechanisms: urolithin A cleans up damaged mitochondria, CoQ10 makes the surviving ones work.

CoQ10 7.1 strong recommend, urolithin A 6.5 worth trying. CoQ10 also runs $15 to $40 a month against $50 to $100.
Mitochondrial ties at 7.0 each. Urolithin A supports mitophagy through PINK1 and Parkin. CoQ10 is a literal component of the respiratory chain between Complex I and Complex III.
CoQ10's cardiovascular case reaches hard outcomes. Q-SYMBIO cut major adverse cardiac events from 26% to 15% in 420 chronic heart-failure patients.
Urolithin A wins muscle at 5.0 to 2.0, and even that is a performance signal rather than hypertrophy.
Both are oversold for healthy, replete people. Neither has controlled evidence for a felt energy lift in someone who already trains and sleeps.
On warfarin, this stops being a contest. CoQ10 resembles vitamin K2 and needs INR monitoring, and urolithin A does not carry that interaction.

At a Glance

Option A

Urolithin A

6.5 / 10 Worth trying

Upside

Efficacy 2.7
Breadth 3.0
Evidence 2.8
Speed 2.3
Durability 2.5
Bioindividuality 3.6

Downside

Safety Risk 1.4
Side Effects 1.4
Cost 4.3
Effort 1.3
Opportunity Cost 2.0
Dependency 1.5
Reversibility 1.2

Best at:

Mitochondrial 7.0
Anti Inflammatory 5.5
Geriatric 5.5
Muscle Growth 5.0

Oral gut-microbial metabolite that supports selective mitophagy. BioHarmony 6.5, worth trying.

Read full BioHarmony report →

Head-to-Head Verdict

Use Case	Winner	Rationale
Mitochondrial	Tie	A genuine 7.0 to 7.0 tie, and the most interesting row here because the two scores mean different things. CoQ10 carries electrons between Complexes I and III, so it is a literal part of the machine, and Banach 2015 showed statins drop plasma CoQ10 by 0.44 micromol per liter. Urolithin A clears broken machines instead: Andreux 2019 measured acylcarnitine and gene-expression shifts in people.
Cardiovascular	Coenzyme Q10 (CoQ10 / Ubiquinol)	CoQ10 takes this 7.5 to 3.0, the widest gap on the page. Q-SYMBIO (Mortensen 2014, n=420) cut major adverse cardiac events from 26% to 15% and halved cardiovascular mortality over two years, and Lei 2017 pooled 14 RCTs for a mortality risk ratio of 0.69. Hodzic Kuerec 2024 found no clear cardiovascular effect for urolithin A. Blood pressure is a null result.
Energy	Coenzyme Q10 (CoQ10 / Ubiquinol)	CoQ10 takes it 6.0 to 4.0, with a hard limit on who benefits. Exercise capacity improved in the heart-failure meta-analysis (Lei 2017), so the gain is real where CoQ10 is depleted: statin users, older adults, cardiac fatigue. In healthy replete people the controlled evidence is thin on both sides, and urolithin A's own report calls subjective energy mixed and unproven.
Antioxidant	Coenzyme Q10 (CoQ10 / Ubiquinol)	CoQ10 takes this 5.5 to 1.0 and it is barely a contest. CoQ10 is the main lipid-phase antioxidant in cell membranes and lipoproteins, regenerating vitamin E and limiting LDL oxidation, and Gao 2012 pooled five trials showing flow-mediated dilation improved with an effect size of 1.70. Urolithin A's own report states it is not primarily an antioxidant.
Endurance Cardio	Tie	Dead even at 4.5 each, and both for the same reason. Each one restores capacity in a compromised population and does close to nothing in an intact engine. Lei 2017 improved exercise capacity in heart-failure patients while healthy-athlete CoQ10 trials stay mixed. Liu 2022 improved muscle endurance in adults aged 65 to 90 while 6-minute walk distance was not clearly significant.
Muscle Growth	Urolithin A	Urolithin A takes this 5.0 to 2.0, and read the number carefully. The human data support a muscle-performance signal rather than hypertrophy: Singh 2022 in middle-aged adults reported strength and exercise-performance gains, with industry funding and no independent replication. CoQ10's muscle relevance is statin symptom relief, which Qu 2018 supports across 12 RCTs. Neither one builds mass.
Fertility Male	Coenzyme Q10 (CoQ10 / Ubiquinol)	CoQ10 takes it 5.0 to 1.0. Several RCTs and meta-analyses report improved sperm concentration, motility and morphology plus lower seminal oxidative stress, with a coherent antioxidant mechanism. The honest limit is that semen parameters have not clearly translated into higher live-birth rates. Urolithin A has no verified human male-fertility endpoint evidence at all.
Fertility Female	Coenzyme Q10 (CoQ10 / Ubiquinol)	CoQ10 takes it 4.5 to 1.0, on thinner ground than the male row. It is widely used in assisted reproduction for older women on an oocyte mitochondrial-function rationale, and small trials show improved ovarian response markers, but clean pregnancy or live-birth evidence is limited. Treat it as a clinician-guided adjunct. Urolithin A has no human evidence here.

Cost Comparison

Intervention	Monthly Cost	Notes
Urolithin A	$50 to $100	Priced 2026-09-07, retail channel, extracted from the source report rather than estimated. That buys branded Mitopure at the studied 500 mg a day dose, the only form validated in the human RCTs. Generic urolithin A is cheaper and unvalidated, with real purity and label-claim problems, so the cheap version is not the same purchase.
CoQ10	$15 to $40	Priced 2026-09-07, retail channel, extracted from the source report. That is generic ubiquinone at 200 mg a day, the top of the 100 to 200 mg protocol range. Better-absorbed ubiquinol runs $30 to $60, which is the form worth paying for over fifty. Take either with the fattiest meal of the day, because absorption is poor without dietary fat.
The difference	Roughly two to six times cheaper on CoQ10	Compare $15 to $40 against $50 to $100. At the extremes that is close to seven times, and at typical mid-range pricing it is closer to three. Either way the cheaper option is also the higher-scoring one, which is rare.That changes the order of operations. Run CoQ10 first for 12 weeks, because it costs less and its assessment window is shorter. Add or switch to urolithin A only if you have a specific mitophagy or muscle-performance target that CoQ10 did not touch.

When to Switch

CoQ10 moves first and settles sooner. First noticeable change lands around week 2, full effect at week 12, and the assessment window is 12 weeks. Urolithin A takes about 4 weeks for a first change, reaches full effect at 16 weeks, and asks for a 16-week window. So CoQ10 gives you a verdict a month earlier for a third of the money, which is why it goes first for almost everyone.

Move from urolithin A to CoQ10 when your reason for shopping is cardiac, statin-related, antioxidant or fertility: those are 7.5, 5.5, 5.0 and 4.5 rows against urolithin A's 3.0, 1.0, 1.0 and 1.0, and no amount of mitophagy closes that. Move the other way after a full 12-week CoQ10 trial at 100 to 200 mg a day with a fat-containing meal left your specific marker unmoved, and your target is mitochondrial quality control or muscle performance rather than heart or oxidative stress.

Running both is defensible on mechanism, but no human trial has tested the combination, so treat a stack as an untested hypothesis you are paying $65 to $140 a month for. One hard override: on warfarin, CoQ10 needs INR monitoring and urolithin A does not, so that decision belongs to your prescriber.

Who Should Pick What?

Statin user with muscle aches, cramps or weakness

Coenzyme Q10 (CoQ10 / Ubiquinol)

Qu 2018 pooled 12 RCTs in 575 people and found CoQ10 significantly reduced muscle pain, weakness, cramp and tiredness, with no change in creatine kinase. Banach 2015 gives the mechanism: statins drop plasma CoQ10 by 0.44 micromol per liter. Taylor 2015 is the honest null, so responses vary.

Adult with chronic heart failure under cardiology care

Coenzyme Q10 (CoQ10 / Ubiquinol)

Q-SYMBIO cut major adverse cardiac events from 26% to 15% and halved cardiovascular mortality at 300 mg a day over two years, and Lei 2017 pooled 14 RCTs for a mortality risk ratio of 0.69. This is an add-on to guideline therapy, never a replacement. Urolithin A has nothing comparable.

Man working on semen parameters with a clinician

Coenzyme Q10 (CoQ10 / Ubiquinol)

Fertility-male 5.0 against 1.0. Multiple RCTs report improved sperm concentration, motility and morphology plus lower seminal oxidative stress. Judge it on a follow-up semen analysis, and know that better parameters have not clearly translated into higher live-birth rates.

Older or sedentary adult with a defined mitophagy or muscle-performance target

Urolithin A

This is the one lane urolithin A owns: muscle 5.0 against 2.0, and Liu 2022 studied adults aged 65 to 90 with muscle-endurance and biomarker signals. Pick the marker first, run 16 weeks of Mitopure at 500 mg a day, and stop if it does not move.

Taking warfarin

Urolithin A

CoQ10 structurally resembles vitamin K2 and can blunt the anticoagulant, so it is contraindicated without INR monitoring. Urolithin A carries no clinically significant interaction in the published human studies. Clear either one with the prescriber who manages your INR before you start.

Fit, well-trained and metabolically healthy, chasing more energy

Tie

Neither, honestly. CoQ10's energy case is a correction for a deficit and the controlled evidence in replete people is thin. I ran Mitopure at 500 mg a day for about 90 days and noticed no clear subjective effect, and I am already fit. Fix training, sleep and protein first.

One mitochondrial supplement, tight budget, over fifty

Coenzyme Q10 (CoQ10 / Ubiquinol)

$15 to $40 a month against $50 to $100, a 12-week verdict instead of 16, and hard outcome data behind it. Buy ubiquinol rather than dry ubiquinone at that age and take it with the fattiest meal of the day.

Pregnant or breastfeeding

Tie

Neither, without clinician guidance. Both reports list pregnancy and nursing as contraindications, urolithin A because no human data exist and CoQ10 because supplement-dose data in those groups is limited. This is a wait, not a risk worth taking for a marginal benefit.

Research Highlights

Mechanism Difference
These two mechanisms are complementary, not redundant, and they share no molecular target. CoQ10 is a lipid-soluble electron carrier that shuttles electrons between Complexes I and III of the respiratory chain to drive ATP production, and doubles as the main membrane-phase antioxidant protecting cell membranes and circulating LDL.Urolithin A never touches the electron chain. It supports selective mitophagy through the PINK1 and Parkin pathway, tagging damaged mitochondria for recycling. CoQ10 makes existing mitochondria work. Urolithin A removes the ones that no longer do. That is why both score 7.0 on the mitochondrial row for opposite reasons.
Safety Comparison
Both are very safe, with one interaction that decides cases. Urolithin A scores 1.4 on safety risk and 1.4 on side effects. CoQ10 scores 1.5 and 1.5, with an observed safe level of 1,200 mg a day per Hidaka 2008 and mild GI upset as the main effect.The difference that matters is warfarin. CoQ10 resembles vitamin K2 and can blunt the anticoagulant, so it needs INR monitoring. Both rule out pregnancy and breastfeeding without clinician guidance, and both want oncology clearance during active treatment.
Cost Comparison
CoQ10 is the cheaper purchase by roughly two to six times. Generic ubiquinone runs $15 to $40 a month at 200 mg a day and better-absorbed ubiquinol runs $30 to $60, both priced 2026-09-07 from retail. Branded Mitopure runs $50 to $100 a month at the studied 500 mg a day dose.Cost decides the order of operations rather than the whole question. CoQ10 costs less and returns a verdict at 12 weeks instead of 16, so it goes first. Running both lands somewhere around $65 to $140 a month, with no human trial of the combination.
Responder Profile
Both of these are corrections for a deficit rather than upgrades for a healthy system, and their own reports say so. CoQ10's benefit concentrates in statin users, chronic heart-failure patients under cardiology care, and adults over fifty whose endogenous production is falling.Urolithin A's human signal concentrates in older adults, sedentary adults and post-illness rebuild phases, plus the large share of people whose gut bacteria make little urolithin A from pomegranate and walnuts. A young, fit, well-fed person who already trains is the wrong responder for either one.
Editorial Verdict
CoQ10 wins this comparison 7.1 to 6.5, takes five of the eight use-case rows, and costs two to six times less. Its cardiovascular case reaches hard outcomes rather than moved markers: Q-SYMBIO cut major adverse cardiac events from 26% to 15% in 420 chronic heart-failure patients.Urolithin A holds one lane, muscle performance at 5.0 against 2.0, and ties the mitochondrial row 7.0 to 7.0 on the opposite mechanism. Buy CoQ10 first unless your target is specifically mitochondrial quality control, or you take warfarin.

Frequently Asked Questions

Is CoQ10 better than urolithin A?: For most people, yes. CoQ10 scores 7.1 against 6.5, takes five of the eight use-case rows, and costs two to six times less. Urolithin A wins the muscle row 5.0 to 2.0 and ties mitochondrial at 7.0 each. If your target is cardiac, statin muscle pain, antioxidant capacity or fertility, CoQ10 is not a close call.
What is the difference between urolithin A and CoQ10?: CoQ10 is a working part of the mitochondrion. It carries electrons between Complexes I and III to make ATP, and protects membranes and LDL from oxidation. Urolithin A is a cleanup signal that supports selective mitophagy through the PINK1 and Parkin pathway, tagging damaged mitochondria for recycling. One runs the machine, the other retires broken ones.
Can I take urolithin A and CoQ10 together?: Mechanistically it makes sense, since clearing damaged mitochondria and supplying the electron carrier are complementary rather than overlapping. No human trial has tested the combination, so treat it as an untested hypothesis costing roughly $65 to $140 a month. Run CoQ10 alone for 12 weeks first, then decide.
Which one is cheaper?: CoQ10, by two to six times. Generic ubiquinone runs $15 to $40 a month at 200 mg a day and ubiquinol runs $30 to $60. Branded Mitopure runs $50 to $100 a month at 500 mg a day. Both priced 2026-09-07. Generic urolithin A is cheaper but was not the material used in any published human trial.
How long before I know if either is working?: CoQ10 gives a first noticeable change around week 2, full effect at week 12, and asks for a 12-week assessment window. Urolithin A takes about 4 weeks for a first change, full effect at 16 weeks, and a 16-week window. Pick your marker before you start, then judge at the window rather than on how you feel in week two.
Will either one give me more energy?: Only if you are starting from a deficit. CoQ10 scores 6.0 on energy and exercise capacity improved in heart-failure patients, but the controlled evidence for healthy replete people is thin. Urolithin A scores 4.0 with mixed subjective reports. I ran Mitopure at 500 mg a day for about 90 days and noticed no clear subjective effect.
Which one helps with statin muscle pain?: CoQ10, and it is not close. Statins lower plasma CoQ10 by 0.44 micromol per liter, and a 12-RCT meta-analysis found CoQ10 significantly reduced muscle pain, weakness, cramp and tiredness. A confirmed-myopathy RCT at 600 mg a day found no benefit, so responses vary. Urolithin A has no evidence here at all.
Should I buy ubiquinol or ubiquinone?: Ubiquinol if you are over fifty or absorb poorly, ubiquinone if price is the constraint. Langsjoen 2014 measured plasma CoQ10 at 4.3 against 2.5 micrograms per milliliter at 200 mg a day of each form. Either way take it with the fattiest meal of the day, because absorption is poor without dietary fat.
Who should avoid these?: Anyone on warfarin should not take CoQ10 without INR monitoring, since it resembles vitamin K2 and can blunt the anticoagulant. Neither belongs in pregnancy or breastfeeding without clinician guidance.CoQ10 also rules out high-dose selenium co-supplementation outside the studied combination, and replacing guideline heart-failure therapy or a needed statin. Urolithin A rules out pediatric use, unverified generic product, and use as a disease treatment.

Evidence Sources

RCT The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure (Q-SYMBIO) (2014) n=420 over 2 years. 300 mg a day cut major adverse cardiac events from 26% to 15% (HR 0.50) and halved cardiovascular mortality.
Systematic review Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials (2017) 14 RCTs, n=2,149. Mortality risk ratio 0.69 and improved exercise capacity. LVEF and NYHA class were not significant.
Systematic review Effects of Coenzyme Q10 on Statin-Induced Myopathy: an updated meta-analysis of randomized controlled trials (2018) 12 RCTs, n=575. CoQ10 significantly reduced muscle pain, weakness, cramp and tiredness, with no change in creatine kinase.
RCT A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy (2015) Crossover RCT, n=41 at 600 mg a day. No benefit on muscle pain, strength or aerobic performance. The honest null counterweight.
Systematic review Statin therapy and plasma coenzyme Q10 concentrations: a systematic review and meta-analysis of placebo-controlled trials (2015) Plasma CoQ10 fell 0.44 micromol per liter on statins. The mechanistic basis for co-supplementing.
Systematic review Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials (2012) 5 trials, n=194. Flow-mediated dilation improved with a standardized mean difference of 1.70. Supports the endothelial and antioxidant case.
Systematic review Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension, Cochrane Database of Systematic Reviews (2016) 2 controlled RCTs, n=50. Systolic and diastolic changes both nonsignificant. The rigorous null on blood pressure.
Review Safety assessment of coenzyme Q10 (CoQ10) (2008) Observed safe level of 1,200 mg a day per person, low toxicity, no serious adverse effects in humans.
RCT Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone (2014) Crossover PK study, n=12 at 200 mg a day each form. Plasma CoQ10 reached 4.3 on ubiquinol against 2.5 micrograms per milliliter on ubiquinone.
RCT The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans (2019) First-in-human urolithin A study. Safety, bioavailability, acylcarnitine shifts and mitochondrial gene-expression effects.
RCT Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in middle-aged adults (2022) Middle-aged adult RCT supporting a strength and performance signal, with industry funding and replication limitations.
RCT Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults (2022) Older-adult RCT. Muscle-endurance and biomarker signals, but 6-minute walk and maximal ATP production were not clearly significant against placebo.
Systematic review Targeting aging with urolithin A in humans: a systematic review (2024) Five human studies, 250 healthy individuals. No clear effect on cardiovascular outcomes, anthropometrics or broad physical function.
Systematic review The effects of urolithin A supplementation on muscle strength, muscle mass and physical performance in humans (2025) Preprint synthesis of three randomized trials. Pooled 6-minute walk estimate crossed null; evidence called insufficient for current muscle-function use.

Glossary

Quick reference for the medical and technical terms used in this comparison.

CoQ10 Coenzyme Q10 (ubiquinone or ubiquinol): A fat-soluble electron carrier in the mitochondrial respiratory chain that doubles as the main lipid-phase antioxidant. The body makes it, and output falls with age and statin use.
Mitophagy Selective Mitochondrial Autophagy: The cell's process for tagging and recycling damaged mitochondria. Narrower than general autophagy. This is urolithin A's whole mechanism.
PINK1 / Parkin PTEN-Induced Kinase 1 and Parkin Pathway: The mitochondrial quality-control pathway that flags damaged mitochondria for cleanup. The route urolithin A acts through.
Complex I / Complex III Respiratory Chain Complexes: Two protein assemblies in the inner mitochondrial membrane. CoQ10 physically shuttles electrons between them to drive ATP production.
Ubiquinol Reduced Form of CoQ10: The better-absorbed form, worth the higher price for older or poor-absorbing users. Ubiquinone is the cheaper oxidized form. The body converts between them.
Mitopure Micronized Urolithin A (Amazentis / Timeline): The only urolithin A preparation used across the published human RCTs. Generic capsule equivalence has not been established.
Q-SYMBIO Coenzyme Q10 heart-failure mortality RCT: The 420-patient two-year trial where 300 mg a day cut major adverse cardiac events from 26% to 15% and halved cardiovascular mortality.
FMD Flow-Mediated Dilation: An ultrasound measure of how well an artery widens in response to blood flow. A standard endothelial-function endpoint, improved by CoQ10 in Gao 2012.
Ellagitannins Pomegranate and Walnut Polyphenols: Food polyphenols that gut bacteria convert into urolithin A. Many adults are low or non-producers, which is why the supplement exists.

Nick Urban Health Optimization Researcher & CHEK Holistic Lifestyle Coach Level 2

I ran Mitopure at 500 mg a day for about 90 days with no clear subjective effect, and I am still evaluating CoQ10, mostly through statin users and older clients

Reviewed Sep 7, 2026 · next review Dec 6, 2026

Find which one fits your biology

Take the BioHarmony Quiz